Building on this evidence, we evaluated whether PV-1 detection could serve as a marker for distant metastases also in other solid tumors known to metastasize via the hematogenous route, such as luminal breast cancer and clear cell renal cell carcinoma (ccRCC). The gene discussed is PLVAP; the disease is breast carcinoma.